Empa Kidney
Research payments
$2,807,263
Through program year 2023, $2,807,263 in research payments was reported against Empa Kidney, across 131 payments.
- Paid by (largest first)
- Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co.KG
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $277,077 | 37 |
| 2022 | Research | $2,530,186 | 94 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- David Tietjen Huntsville, AL Named on 3 payments
- Rajesh Pradhan Rapid City, SD Named on 3 payments
- Lenita Hanson Port Charlotte, FL Named on 3 payments
- Shweta Bansal San Antonio, TX Named on 3 payments
- Danny Sugimoto Chicago, IL Named on 3 payments
- Kenneth Boren Mesa, AZ Named on 3 payments
- Sergio Rovner El Paso, TX Named on 3 payments
- Lance Sloan Lufkin, TX Named on 3 payments
- Pablo Pergola San Antonio, TX Named on 3 payments
- Elias Ugwu North Las Vegas, NV Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.